GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
T45.605D
Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
ICD10CM code
Similar Codes
ICD10CM codes
T45.605D
- Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.605A
- Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.695D
- Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
T45.695A
- Adverse effect of other fibrinolysis-affecting drugs, initial encounter
T45.605S
- Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
T45.605
- Adverse effect of unspecified fibrinolysis-affecting drugs
T45.606D
- Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.604D
- Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter
T45.694D
- Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter
T45.615D
- Adverse effect of thrombolytic drugs, subsequent encounter
HCPCS codes
G8969
- Documentation of patient reason(s) for not prescribing warfarin or another fda-approved oral anticoa
G8696
- Antithrombotic therapy prescribed at discharge
G8968
- Documentation of medical reason(s) for not prescribing warfarin or another fda-approved anticoagulan
G9929
- Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardi
G9928
- Warfarin or another fda-approved anticoagulant not prescribed, reason not given
G8971
- Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
D9630
- OTHER DRUGS AND/OR MEDICAMENTS
J3246
- Injection, tirofiban hcl, 0.25 mg
G8972
- One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboe
D9610
- THERAPEUTIC PARENTERAL DRUG
CPT4 codes
85390
- Fibrinolysins or coagulopathy screen, interpretation and report
85410
- Fibrinolytic factors and inhibitors; alpha-2 antiplasmin
85397
- Coagulation and fibrinolysis, functional activity, not otherwise specified (eg, ADAMTS-13), each ana
85290
- Clotting; factor XIII (fibrin stabilizing)
85415
- Fibrinolytic factors and inhibitors; plasminogen activator
32562
- Instillation(s), via chest tube/catheter, agent for fibrinolysis (eg, fibrinolytic agent for break u
36593
- Declotting by thrombolytic agent of implanted vascular access device or catheter
85366
- Fibrin(ogen) degradation (split) products (FDP) (FSP); paracoagulation
37195
- Thrombolysis, cerebral, by intravenous infusion
85210
- Clotting; factor II, prothrombin, specific